摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-chlorophenylthio)-5-nitrobenzenesulfonamide | 95175-11-4

中文名称
——
中文别名
——
英文名称
2-(4-chlorophenylthio)-5-nitrobenzenesulfonamide
英文别名
5-Nitro-2-(4-chlor-phenylmercapto)-benzolsulfonamid;2-(4-chloro-phenylsulfanyl)-5-nitro-benzenesulfonamide;2-(4-Chlorophenyl)sulfanyl-5-nitrobenzenesulfonamide;2-(4-chlorophenyl)sulfanyl-5-nitrobenzenesulfonamide
2-(4-chlorophenylthio)-5-nitrobenzenesulfonamide化学式
CAS
95175-11-4
化学式
C12H9ClN2O4S2
mdl
——
分子量
344.799
InChiKey
KRVFWVPLYMIACX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    21
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    140
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(4-chlorophenylthio)-5-nitrobenzenesulfonamidesodium hydroxide 作用下, 以 甲醇 为溶剂, 生成 1-<4-Chlor-phenyl>-5-nitro-1H-1,3,2-benzodithiazol-3,3-dioxid
    参考文献:
    名称:
    Wagner,A.W.; Banholzer,R., Chemische Berichte, 1963, vol. 96, p. 1177 - 1186
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    Synthesis and Pharmacological Evaluation of Novel Nitrobenzenic Thromboxane Modulators as Antiplatelet Agents Acting on Both the Alpha and Beta Isoforms of the Human Thromboxane Receptor
    摘要:
    Thromboxane A(2) ( TXA(2)) is an arachidonic acid metabolite involved in pathologies such as stroke, myocardial infarction, and atherosclerosis. Consequently, the design of TXA2 receptor ( TP) antagonists remains of great interest in cardiovascular medicine. The actions of TXA2 are mediated by its specific G-protein coupled receptor of which two alternative spliced isoforms, TP alpha and TP beta, have been described in humans. In this study, we report the synthesis of a series of original N-alkyl-N'-[2-( cycloalkyl, alkylaryl)-5-nitrobenzenesulfonyl] urea and N-alkyl-N'-[ 2-( alkylaryl)-5-nitrobenzenesulfonyl]-N"-cyanoguanidines and outline their pharmacological evaluation using the individual TP alpha and TP beta isoforms. Among compounds analyzed, several of them exhibited greater affinity and/or functional activity for either TP alpha or TP beta. The most promising molecules were also found to be antiplatelet agents. From the present results, structural features involved in isoform selectivity can be proposed, and thereby several lead compounds have been identified for the further development of selective TP isoform antagonists.
    DOI:
    10.1021/jm060108a
点击查看最新优质反应信息

文献信息

  • Synthesis and Pharmacological Evaluation of Novel Nitrobenzenic Thromboxane Modulators as Antiplatelet Agents Acting on Both the Alpha and Beta Isoforms of the Human Thromboxane Receptor
    作者:Julien Hanson、Denis Reynaud、Na Qiao、Philippe Devel、Anne-Lise Moray、Jean-François Renard、Leanne P. Kelley、Jean-Yves Winum、Jean-Louis Montero、B. Therese Kinsella、Bernard Pirotte、Cecil R. Pace-Asciak、Jean-Michel Dogné
    DOI:10.1021/jm060108a
    日期:2006.6.1
    Thromboxane A(2) ( TXA(2)) is an arachidonic acid metabolite involved in pathologies such as stroke, myocardial infarction, and atherosclerosis. Consequently, the design of TXA2 receptor ( TP) antagonists remains of great interest in cardiovascular medicine. The actions of TXA2 are mediated by its specific G-protein coupled receptor of which two alternative spliced isoforms, TP alpha and TP beta, have been described in humans. In this study, we report the synthesis of a series of original N-alkyl-N'-[2-( cycloalkyl, alkylaryl)-5-nitrobenzenesulfonyl] urea and N-alkyl-N'-[ 2-( alkylaryl)-5-nitrobenzenesulfonyl]-N"-cyanoguanidines and outline their pharmacological evaluation using the individual TP alpha and TP beta isoforms. Among compounds analyzed, several of them exhibited greater affinity and/or functional activity for either TP alpha or TP beta. The most promising molecules were also found to be antiplatelet agents. From the present results, structural features involved in isoform selectivity can be proposed, and thereby several lead compounds have been identified for the further development of selective TP isoform antagonists.
  • Wagner,A.W.; Banholzer,R., Chemische Berichte, 1963, vol. 96, p. 1177 - 1186
    作者:Wagner,A.W.、Banholzer,R.
    DOI:——
    日期:——
查看更多